Loading
Henry Schein Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 11 Aug 2025.
Henry Schein Inc: what insiders have been doing
Henry Schein Inc, classified in the Healthcare & Pharma sector, is a listed company based in Melville, United States, founded in 1932. Its insiders report their share dealings to SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Henry Schein Inc logged 53 filings by 22 insiders.
No insider bought on the market over the period, while 5 insiders filed 5 sales totalling €2.9M. At €2.1M, the sale published on 27 February 2026 by Bergman Stanley M is the largest of the period.
Compared with its exchange (5,813 companies, median 19 filings), a count of 53 filings is above the norm. Our records for Henry Schein Inc go back to 2016, with 2 purchases and 44 sales on the open market in total. On the fundamentals side, the SEC filing (10-K) for the period ending 27 December 2025 lists revenue at 13.18 bn USD and net income at 398.0 m USD.
Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
287
Thresholds
n/a
Buy Volume
€652,072
2 ops. · all time
Sell Volume
€31M
44 ops. · all time
Who traded when
BuySaleLaskawy Philip A2 sales
Connett Bradford C1 sale
Kurt P. Kuehn1 sale
Mark E. Mlotek1 sale
Michael S. Ettinger1 sale
Stanley M. Bergman1 sale
+2 other insiders
Since the insiders bought
- +34.4%Entry US$67.50 · Close at T+365 US$90.74
- -9.6%Entry US$86.86 · Close at T+365 US$78.56
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Henry Schein Inc Buy (bullish), based on 15 analysts. Average price target: US$96.87.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 13,068 of 24,148 companies
49.2
score / 100
Value55
Quality44
FCF yld5.3%
Earn yld4.0%
EV/EBITDA13.8x
ROE8.9%
Gross mgn31%
Net mgn3.0%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$86.99
Analyst consensus
15 analystsBuy
US$64.00Target US$96.87(+11%)US$110.00
Income statement
RevenueUS$13.2B
Gross profitUS$4.1B31% margin
EBITDAUS$964M7% margin
Net incomeUS$398M3.0% margin
Valuation
PER (trailing)25.4x
PER (forward)14.5x
P/Book3.1x
Beta0.84
Balance sheet & cash
Market capUS$9.9B
Total debtUS$3.4B
Free Cash FlowUS$521M
Debt / Equity81%
Profitability & ownership
ROE8.9%
ROA4.4%
% insiders0.8%
% institutions112.2%
Last declaration on 9 September 2026
Declarations287 total
603 shares@ US$88.860.0005% mcap13.5% of flowCommon Stock, par value $0.01 per shareSEC:0002025230-26-000008:0
3,984 shares0Common Stock, par value $0.01 per shareSEC:0002025230-26-000008:1
35,257 shares@ US$90.120.19% mcap70.0% of flowCommon StockSEC144:0001968582-26-000839
28,791 shares@ US$84.290.025% mcap100.0% of flowCommonSEC144:0001959173-26-004962
16,933 shares@ US$81.0930.0% of flowCommon StockSEC144:0001968582-26-000617
2,215 sharesCommon Stock, par value $0.01 per shareSEC:0001190297-26-000004:0
50 shares0Common Stock, par value $0.01 per shareSEC:0001193125-26-237318:0
1,040 shares0Common Stock, par value $0.01 per shareSEC:0001193125-26-234868:0
1,355 shares@ US$72.7943.3% of flowCommon Stock, par value $0.01 per shareSEC:0002057014-26-000008:0
1,300 shares0Common Stock, par value $0.01 per shareSEC:0001577158-26-000006:0
463 shares@ US$74.61100.0% of flowCommon Stock, par value $0.01 per shareSEC:0002070926-26-000006:0
587 shares@ US$74.6119.3% of flowCommon Stock, par value $0.01 per shareSEC:0002057014-26-000006:0
1,401 shares@ US$74.6126.8% of flowCommon Stock, par value $0.01 per shareSEC:0002025230-26-000006:0
5,216 shares@ US$74.6167.7% of flowCommon Stock, par value $0.01 per shareSEC:0001924845-26-000006:0
5,928 shares@ US$74.616.2% of flowCommon Stock, par value $0.01 per shareSEC:0001194352-26-000008:0
400 shares0Common Stock, par value $0.01 per shareSEC:0001008413-26-000008:0
970 shares0Common Stock, par value $0.01 per shareSEC:0001008413-26-000006:0
2,844 shares@ US$78.96128.9% of flowCommon Stock, par value $0.01 per shareSEC:0001275613-26-000004:0
53,206 shares0Common Stock, par value $0.01 per shareSEC:0002057014-26-000004:0
20,296 shares0Common Stock, par value $0.01 per shareSEC:0001924845-26-000004:0
64,433 shares0Common Stock, par value $0.01 per shareSEC:0001777440-26-000007:0
27,061 shares0Common Stock, par value $0.01 per shareSEC:0001577158-26-000004:0
300 shares0Common Stock, par value $0.01 per shareSEC:0001194352-26-000006:0
60,631 shares0Common Stock, par value $0.01 per shareSEC:0002025230-26-000004:0
7,087 shares0Common Stock, par value $0.01 per shareSEC:0002070926-26-000004:0
25 of 287 declarations
About Henry Schein Inc
Henry Schein Inc. is a leading provider of healthcare solutions for office-based dental and medical practitioners. The company is listed on the U.S. market, NASDAQ (United States), was founded in 1932, and is headquartered in Melville, New York. What began as a dental-focused distributor has evolved into a broader healthcare platform spanning consumables, equipment, specialty products, software, and value-added services for clinicians and practice owners.
The business is now organized around three core segments. First, Global Distribution and Value-Added Services covers the sale of branded and private-label merchandise, equipment, technical services, and advisory offerings such as practice transition, consulting, continuing education, and financial services. Second, Global Specialty Products includes manufacturing, marketing, and sales of dental implant and biomaterial products, as well as endodontic, orthodontic, orthopedic, and other healthcare-related products. Third, Global Technology comprises practice management software, e-services, and related digital solutions. This mix of distribution, proprietary products, and software creates a diversified model with recurring demand characteristics and a broad customer base.
Read moreShow less
From a competitive standpoint, Henry Schein holds a strong position in the dental and medical office supply chain, supported by its scale, logistics footprint, technical service capabilities, and integrated offering. The company operates in 33 countries and territories, giving it meaningful international reach beyond its U.S. home market. Its competitive advantages are particularly visible in relationships with independent practitioners, where product availability, service quality, software integration, and equipment support matter as much as price. At the same time, the company faces intense competition from specialty distributors, manufacturers, and online commerce platforms.
Recent developments are important for investors. In January 2025, Henry Schein announced a strategic investment by KKR, board changes, and a value-creation collaboration framework. The company also updated its reportable segment structure in 2025 to better align external reporting with management’s internal view of the business. Operationally, 2025 results highlighted growth in medical distribution, specialty products, and technology, supported by underlying demand from dental and physician offices, acquisitions, and expanding cloud-based software offerings such as Dentrix Ascend and Dentally. For international equity investors, HSIC represents a mature U.S. healthcare franchise with global exposure, a resilient end-market, and an evolving mix of distribution, specialty manufacturing, and digital workflow solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
